Complete response rates (no detectable cancer) were consistently superior in patients receiving Liso-Cel. These outcomes represent a remarkable step forward, making Liso-Cel the new standard of ...

Among T+L patients, the objective response rate was 20% in the tailored therapy arm vs. 11.8% in the standard-of-care arm. "The superior outcomes observed in patients with concordant biopsy ...

What clinicians think are the less desirable outcomes for patients with pneumonia may not align with what patients think, ...

‘Outcome measures’ refer to a multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients. Simply put, they are the various measures ...

Modern registries now include patient-reported outcomes, disease-specific clinician assessments, administrative claims, electronic health records (EHRs), and lab/imaging results. Additionally ...

The goal is to improve the likelihood that outcome variation reflects the quality of care, rather than differences in patients who are treated. To effectively risk-adjust, the data from all sites ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.